1. Departments of Pharmacology and Toxicology (P.E.S., E.G.R., A.-M.M., B.C.R., E.H.), University of Lausanne, CH-1005 Lausanne, Switzerland;
2. Division of Nephrology (R.S., J.W., D.P.), Department of Medicine, University of California, San Francisco, California 94122;
3. Institute of Pathology (J.-C.S., S.R.) CHUV and University of Lausanne, CH-1011 Lausanne, Switzerland;
4. Service of Infectious Diseases (T.R.), Department of Medicine; and Service of Endocrinology, Diabetology, CHUV and University of Lausanne, CH-1011 Lausanne, Switzerland;
5. Metabolism (M.-J.V., F.P.P.), Department of Medicine, CHUV and University of Lausanne, CH-1011 Lausanne, Switzerland;
6. Department of Biochemistry (O.G., V.P.), University of Lausanne, CH-1066 Epalinges, Switzerland;
7. Medical Genetics (K.N., R.C.), University of Lausanne, CH-1005 Lausanne, Switzerland;
8. Ludwig Center for Cancer Research of the University of Lausanne (A.W.), University of Lausanne, CH-1066 Epalinges, Switzerland;
9. Swiss Institute for Experimental Cancer Research (ISREC), Ecole Polytechnique Fédérale de Lausanne (F.B.), CH-1015 Lausanne, Switzerland
10. Service of Nephrology (M.M.), Centre Hospitalier Universitaire Vaudois (CHUV);, CHUV and University of Lausanne, CH-1011 Lausanne, Switzerland;